{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:09:41Z","timestamp":1772168981382,"version":"3.50.1"},"update-to":[{"DOI":"10.12688\/f1000research.23996.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000}}],"reference-count":62,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD084633"],"award-info":[{"award-number":["R01HD084633"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM012373"],"award-info":[{"award-number":["R01LM012373"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM12907"],"award-info":[{"award-number":["R01LM12907"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["K01ES025434"],"award-info":[{"award-number":["K01ES025434"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>\n                    <ns4:bold>Background:<\/ns4:bold>\n                    Coronavirus disease (COVID-19) is an infectious disease discovered in 2019 and currently in outbreak across the world. Lung injury with severe respiratory failure is the leading cause of death in COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there still lacks efficient treatment for COVID-19 induced lung injury and acute respiratory failure.\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Methods:<\/ns4:bold>\n                    Inhibition of angiotensin-converting enzyme 2 (ACE2) caused by the spike protein of SARS-CoV-2 is the most plausible mechanism of lung injury in COVID-19. We performed drug repositioning analysis to identify drug candidates that reverse gene expression pattern in L1000 lung cell line HCC515 treated with ACE2 inhibitor. We confirmed these drug candidates by similar bioinformatics analysis using lung tissues from patients deceased from COVID-19. We further investigated deregulated genes and pathways related to lung injury, as well as the gene-pathway-drug candidate relationships.\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Results:<\/ns4:bold>\n                    We propose two candidate drugs, COL-3 (a chemically modified tetracycline) and CGP-60474 (a cyclin-dependent kinase inhibitor), for treating lung injuries in COVID-19. Further bioinformatics analysis shows that 12 significantly enriched pathways (P-value &lt;0.05) overlap between HCC515 cells treated with ACE2 inhibitor and human COVID-19 patient lung tissues. These include signaling pathways known to be associated with lung injury such as TNF signaling, MAPK signaling and chemokine signaling pathways. All 12 pathways are targeted in COL-3 treated HCC515 cells, in which genes such as RHOA, RAC2, FAS, CDC42 have reduced expression. CGP-60474 shares 11 of 12 pathways with COL-3 and common target genes such as RHOA. It also uniquely targets other genes related to lung injury, such as CALR and MMP14.\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Conclusions:<\/ns4:bold>\n                    This study shows that ACE2 inhibition is likely part of the mechanisms leading to lung injury in COVID-19, and that compounds such as COL-3 and CGP-60474 have potential as repurposed drugs for its treatment.\n                  <\/ns4:p>","DOI":"10.12688\/f1000research.23996.2","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T06:50:22Z","timestamp":1598424622000},"page":"609","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Prediction of repurposed drugs for treating lung injury in COVID-19"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1719-9290","authenticated-orcid":false,"given":"Bing","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Garmire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1054-1062","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID-19 in Wuhan, China: A Retrospective Cohort Study.","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"374-80","DOI":"10.1001\/jama.290.3.374","article-title":"Acute Respiratory Distress Syndrome in Critically Ill Patients With Severe Acute Respiratory Syndrome.","volume":"290","author":"T Lew","year":"2003","journal-title":"JAMA."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"565-574","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding.","volume":"395","author":"R Lu","year":"2020","journal-title":"Lancet."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"1864-8","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed With Receptor.","volume":"309","author":"F Li","year":"2005","journal-title":"Science."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and Its Immune Cross-Reactivity With SARS-CoV.","volume":"11","author":"X Ou","year":"2020","journal-title":"Nat Commun."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"523-34","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: Recent Insights Into Emerging Coronaviruses.","volume":"14","author":"E de Wit","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"271-280.e8","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.","volume":"181","author":"M Hoffmann","year":"2020","journal-title":"Cell."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"873-82","DOI":"10.1128\/JVI.02062-10","article-title":"A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry.","volume":"85","author":"A Shulla","year":"2011","journal-title":"J Virol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"450-4","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus.","volume":"426","author":"W Li","year":"2003","journal-title":"Nature."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"875-9","DOI":"10.1038\/nm1267","article-title":"A Crucial Role of Angiotensin Converting Enzyme 2 (ACE2) in SARS Coronavirus-Induced Lung Injury.","volume":"11","author":"K Kuba","year":"2005","journal-title":"Nat Med."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"7809-14","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-alpha-converting Enzyme by the Spike Protein of SARS-CoV and ACE2 Induces TNF-alpha Production and Facilitates Viral Entry.","volume":"105","author":"S Haga","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-12","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.004655","article-title":"SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems.","author":"D Blanco-Melo","year":"2020","journal-title":"bioRxiv."},{"key":"ref-13","article-title":"lanagarmire\/COVID19-Drugs-LungInjury: Prediction of repurposed drugs for treating lung injury in COVID-19 (Version v1.0.0).","year":"2020","journal-title":"Zenodo."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"1437-52 e17","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.","volume":"171","author":"A Subramanian","year":"2017","journal-title":"Cell."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated Estimation of Fold Change and Dispersion for RNA-seq Data With DESeq2.","volume":"15","author":"M Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"44-57","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.","volume":"4","author":"D Huang","year":"2009","journal-title":"Nat Protoc."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"2818-26","DOI":"10.1093\/bioinformatics\/btz006","article-title":"Breaking the Paradigm: Dr Insight Empowers Signature-Free, Enhanced Drug Repurposing.","volume":"35","author":"J Chan","year":"2019","journal-title":"Bioinformatics."},{"key":"ref-18","article-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016"},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"2498-504","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks.","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"186-210","DOI":"10.1002\/wsbm.1337","article-title":"In Silico Methods for Drug Repurposing and Pharmacology.","volume":"8","author":"R Hodos","year":"2016","journal-title":"Wiley Interdiscip Rev Syst Biol Med."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","article-title":"Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data.","volume":"3","author":"M Sirota","year":"2011","journal-title":"Sci Transl Med."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"313-21","DOI":"10.1097\/CCM.0b013e3182a2727d","article-title":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure.","volume":"42","author":"C Wang","year":"2014","journal-title":"Crit Care Med."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"638-49","DOI":"10.1089\/adt.2015.0003.drrr","article-title":"Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.","volume":"13","author":"O Perwitasari","year":"2015","journal-title":"Assay Drug Dev Technol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"431-9","DOI":"10.1016\/j.virol.2008.04.040","article-title":"Hsp90 inhibitors reduce influenza virus replication in cell culture.","volume":"377","author":"G Chase","year":"2008","journal-title":"Virology."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"2899-914","DOI":"10.1111\/febs.12828","article-title":"Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein \u03b1-actinin-4 for viral replication.","volume":"281","author":"S Sharma","year":"2014","journal-title":"FEBS J."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1038\/s41598-020-59716-7","article-title":"Narciclasine improves outcome in sepsis among neonatal rats via inhibition of calprotectin and alleviating inflammatory responses.","volume":"10","author":"M Kingsley","year":"2020","journal-title":"Sci Rep."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fcimb.2017.00267","article-title":"Geldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus.","volume":"7","author":"C Wang","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"52-8","DOI":"10.1016\/j.resp.2014.10.006","article-title":"Biomarkers in acute lung injury.","volume":"209","author":"D Mokra","year":"2015","journal-title":"Respir Physiol Neurobiol."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"4274-82","DOI":"10.4049\/jimmunol.1202437","article-title":"TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury.","volume":"190","author":"B Patel","year":"2013","journal-title":"J Immunol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"143-51","DOI":"10.1016\/j.tox.2009.05.010","article-title":"Role of MAPK\/AP-1 signaling pathway in the protection of CEES-induced lung injury by antioxidant liposome.","volume":"261","author":"S Mukhopadhyay","year":"2009","journal-title":"Toxicology."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"104-12","DOI":"10.1111\/j.1749-6632.1996.tb32572.x","article-title":"Role of complement, chemokines, and regulatory cytokines in acute lung injury.","volume":"796","author":"P Ward","year":"1996","journal-title":"Ann N Y Acad Sci."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"260-6","DOI":"10.1016\/j.biocel.2004.02.030","article-title":"Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum.","volume":"37","author":"P Gelebart","year":"2005","journal-title":"Int J Biochem Cell Biol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"271-6","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases.","volume":"6","author":"K Kuba","year":"2006","journal-title":"Curr Opin Pharmacol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"L156-64","DOI":"10.1152\/ajplung.00313.2002","article-title":"Angiotensin II and the fibroproliferative response to acute lung injury.","volume":"286","author":"R Marshall","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"589-94","DOI":"10.1097\/SHK.0000000000001067","article-title":"Soluble Epoxide Hydrolase Plays a Vital Role in Angiotensin II-Induced Lung Injury in Mice.","volume":"50","author":"W Tao","year":"2018","journal-title":"Shock."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"e5431","DOI":"10.1590\/1414-431X20165431","article-title":"Angiotensin-(1-7) inhibits inflammation and oxidative stress to relieve lung injury induced by chronic intermittent hypoxia in rats.","volume":"49","author":"W Lu","year":"2016","journal-title":"Braz J Med Biol Res."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"723-36","DOI":"10.1165\/rcmb.2012-0451OC","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas axis protects against lung fibrosis by inhibiting the MAPK\/NF-kappaB pathway.","volume":"50","author":"Y Meng","year":"2014","journal-title":"Am J Respir Cell Mol Biol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"1301-13","DOI":"10.2174\/1389450117666160727142401","article-title":"The Anti-Inflammatory Potential of ACE2\/Angiotensin-(1-7)\/Mas Receptor Axis: Evidence from Basic and Clinical Research.","volume":"18","author":"T Rodrigues Prestes","year":"2017","journal-title":"Curr Drug Targets."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"241-58","DOI":"10.1089\/ars.2013.5818","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1-7)\/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA\/Rho kinase pathway.","volume":"22","author":"Y Meng","year":"2015","journal-title":"Antioxid Redox Signal."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"145-51","DOI":"10.3760\/cma.j.issn.0254-6450.2020.02.003","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.","volume":"41","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"497-506","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"C Huang","year":"2020","journal-title":"Lancet."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1-6","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).","volume":"5","author":"R Inciardi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"4710-22","DOI":"10.1074\/jbc.M114.547596","article-title":"Lipopolysaccharide-induced lung injury involves the nitration-mediated activation of RhoA.","volume":"289","author":"R Rafikov","year":"2014","journal-title":"J Biol Chem."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"104736","DOI":"10.1016\/j.phrs.2020.104736","article-title":"Acute lung injury: The therapeutic role of Rho kinase inhibitors.","volume":"155","author":"F Abedi","year":"2020","journal-title":"Pharmacol Res."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"L1091-102","DOI":"10.1152\/ajplung.90471.2008","article-title":"Regulation of inflammation by Rac2 in immune complex-mediated acute lung injury.","volume":"297","author":"J Dooley","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1465-9921-15-71","article-title":"Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis.","volume":"15","author":"N Arizmendi","year":"2014","journal-title":"Respir Res."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"4069-75","DOI":"10.4049\/jimmunol.175.6.4069","article-title":"Fas-mediated acute lung injury requires fas expression on nonmyeloid cells of the lung.","volume":"175","author":"G Matute-Bello","year":"2005","journal-title":"J Immunol."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"e604-13","DOI":"10.1097\/CCM.0000000000001601","article-title":"Intratracheal Administration of Small Interfering RNA Targeting Fas Reduces Lung Ischemia-Reperfusion Injury.","volume":"44","author":"L Del Sorbo","year":"2016","journal-title":"Crit Care Med."},{"key":"ref-49","first-page":"22-35","article-title":"Impact of chemically-modified tetracycline 3 on intertwined physiological, biochemical, and inflammatory networks in porcine sepsis\/ARDS.","volume":"5","author":"D Sadowsky","year":"2015","journal-title":"Int J Burns Trauma."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"348-56","DOI":"10.1097\/01.shk.0000180619.06317.2c","article-title":"Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model.","volume":"24","author":"J Steinberg","year":"2005","journal-title":"Shock."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"424-32","DOI":"10.1097\/SHK.0b013e318245f2f9","article-title":"Chemically modified tetracycline 3 prevents acute respiratory distress syndrome in a porcine model of sepsis + ischemia\/reperfusion-induced lung injury.","volume":"37","author":"S Roy","year":"2012","journal-title":"Shock."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"580-9","DOI":"10.1016\/j.phrs.2011.06.012","article-title":"Jack of all trades: pleiotropy and the application of chemically modified tetracycline-3 in sepsis and the acute respiratory distress syndrome (ARDS).","volume":"64","author":"S Roy","year":"2011","journal-title":"Pharmacol Res."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"L580-7","DOI":"10.1152\/ajplung.00270.2005","article-title":"Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury.","volume":"291","author":"J Kim","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"245-52","DOI":"10.1006\/jsre.2001.6180","article-title":"Metalloproteinase inhibition prevents acute respiratory distress syndrome.","volume":"99","author":"D Carney","year":"2001","journal-title":"J Surg Res."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"400-6","DOI":"10.1161\/01.cir.100.4.400","article-title":"Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass.","volume":"100","author":"D Carney","year":"1999","journal-title":"Circulation."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"419-26","DOI":"10.1016\/j.athoracsur.2010.04.052","article-title":"A tetracycline analog improves acute respiratory distress syndrome survival in an ovine model.","volume":"90","author":"X Zhou","year":"2010","journal-title":"Ann Thorac Surg."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fimmu.2020.00011","article-title":"Calreticulin Blockade Attenuates Murine Acute Lung Injury by Inducing Polarization of M2 Subtype Macrophages.","volume":"11","author":"Z Jiang","year":"2020","journal-title":"Front Immunol."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"487-97","DOI":"10.1007\/s00109-017-1510-z","article-title":"Matrix metalloproteinase-14 Triggers an Anti-Inflammatory Proteolytic Cascade in Endotoxemia.","volume":"95","author":"A Aguirre","year":"2017","journal-title":"J Mol Med (Berl)."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12859-018-2395-8","article-title":"Drug Candidate Identification Based on Gene Expression of Treated Cells Using Tensor Decomposition-Based Unsupervised Feature Extraction for Large-Scale Data.","volume":"19","author":"Y Taguchi","year":"2019","journal-title":"BMC Bioinformatics."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"375-80","DOI":"10.1097\/SHK.0b013e3182656e7b","article-title":"Cyclin-dependent Kinase Inhibition Reduces Lung Damage in a Mouse Model of Ventilator-Induced Lung Injury.","volume":"38","author":"A Hoogendijk","year":"2012","journal-title":"Shock."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"14969","DOI":"10.1038\/s41598-018-33039-0","article-title":"LINCS L1000 Dataset-Based Repositioning of CGP-60474 as a Highly Potent Anti-Endotoxemic Agent.","volume":"8","author":"H Han","year":"2018","journal-title":"Sci Rep."},{"key":"ref-62","article-title":"Prediction of repurposed drugs for treating lung injury in COVID-19 [Data set].","author":"B He","year":"2020","journal-title":"Zenodo."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-609\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-609\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-609\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T06:05:11Z","timestamp":1599026711000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-609\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":62,"URL":"https:\/\/doi.org\/10.12688\/f1000research.23996.2","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.28930.r70269","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.28930.r70268","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.28930.r70269","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.28930.r70268","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-609\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.28930.r70268, Xia Yang, Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA, USA, 02 Sep 2020, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/9-609\/v2#referee-response-70268","order":0,"name":"referee-response-70268","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.28930.r70269, Leng Han, Shengli Li, Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA, 26 Aug 2020, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/9-609\/v2#referee-response-70269","order":1,"name":"referee-response-70269","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This research was supported by the National Institute of Environmental Health Sciences through funds provided by the trans-NIH Big Data to Knowledge (BD2K) initiative [K01ES025434]; the US National Library of Medicine [R01 LM012373, R01 LM12907]; and the National Institute of Child Health and Human Development [R01 HD084633; to L.X. Garmire].","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}